Feed Insights Top Reports Pricing

⌘K

16:04:04·37d

SECFilingvia Quantisnow

SEC Form 10-Q filed by Blend Labs Inc.

ByQuantisnow·Wall Street's wire, on your screen.

BLND· Blend Labs Inc.

Technology

Plus alert sent

Quantisnow Plus members were alerted at 16:04:06 ET - 2.2s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment BLND files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BLND (Blend Labs Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Director Haveli Investments, L.P. bought $1,882,391 worth of shares (1,118,935 units at $1.68) (SEC Form 4)
Director Haveli Investments, L.P. bought $421,335 worth of shares (268,606 units at $1.57) (SEC Form 4)
Director Haveli Investments, L.P. bought $1,540,215 worth of shares (1,043,628 units at $1.48) (SEC Form 4)
PRINCIPAL ACCOUNTING OFFICER Tkach Oxana sold $8,831 worth of shares (5,625 units at $1.57) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 117,447 units (SEC Form 4)
Head of Product Tech & Cust Op Venkatramani Srinivasan converted options into 81,250 shares and covered exercise/tax liability with 29,372 shares, increasing direct ownership by 25% to 259,390 units (SEC Form 4) to cover withholding tax

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022